An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device

Hollis, I. B., Jennings, D. L., Krim, S., Ton, V.-K., Ducharme, A., Cowger, J., Looby, M., Eulert-Green, J. J., Bansal, N., Horn, E., Byku, M., Katz, J., Michaud, C. J., Rajapreyar, I., Campbell, P., Vale, C., Cosgrove, R., Hernandez-Montfort, J., Otero, J., … Ratnagiri, R. K. (2024). An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device. The Journal of Heart and Lung Transplantation, 43(8), 1199–1234. https://doi.org/10.1016/j.healun.2024.04.065
Authors:
Ian B. Hollis
Douglas L. Jennings
Selim Krim
Van-Khue Ton
Anique Ducharme
Jennifer Cowger
Mary Looby
J.J. Eulert-Green
Neha Bansal
Ed Horn
Mirnela Byku
Jason Katz
C.J. Michaud
Indranee Rajapreyar
Patrick Campbell
Cassandra Vale
Richard Cosgrove
Jaime Hernandez-Montfort
Jessica Otero
Amanda Ingemi
Shashi Raj
Phillip Weeks
Richa Agarwal
Elena S. Martinez
Laurens F. Tops
Mustafa M. Ahmed
Amy Kiskaddon
Jamila Kremer
Mary Keebler
Ravi K. Ratnagiri
Affiliated Authors:
Douglas L. Jennings
Columbia Affiliation:
Author Keywords:
anticoagulation
antiplatelet medications
continuous-flow ventricular assist device
hemocompatibility
hemorrhage
thrombosis
vitamin k antagonists
Publication Type:
Article
Unique ID:
10.1016/j.healun.2024.04.065
PMID:
Publication Date:
Data Source:
Scopus

Record Created: